17 May 2021 - Melbana Energy Limited (ASX:MAY) Executive Chairman Andrew Purcell provides an update on the company's key Cuban onshore oil project, including preparation for its two exploration well program scheduled for Q3 2021 and its sale of WA-488-P permit (containing the Beehive Prospect) to a wholly owned Australian subsidiary of the US company EOG Resources, Inc (NYSE:EOG).

12 May 2021 - Galan Lithium (ASX:GLN) Managing Director Juan Pablo Vargas de la Vega provides an update on they company's key Hombre Muerto lithium brine project in the Catamarca province of Argentina.

26 Apr 2021 - Praemium Limited (ASX:PPS) CEO and Managing Director Michael Ohanessian talks about the company's strong 1H21 results, the successful acquisition of Powerwrap, platform enhancements and outlook.

23 Apr 2021 - Theta Gold Mines Limited (ASX:TGM, OTCQB:TGMGF) CEO for Africa, Mitford Mundell, talks about the company's projects and its plans to bring open-pit mining to historical underground mines and exploit old workings.

23 Apr 2021 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director Garry Crole discusses the company's FY21 profit update and guidance.

23 Apr 2021 - Capral Limited (ASX:CAA) Managing Director Tony Dragicevich talks about the company's strong FY20 results despite COVID, its product mix, operating environment and outlook.

16 Apr 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook talks about the growing demand for digital payments and the opportunities this presents for the company.

06 Apr 2021 - LaserBond Limited (ASX:LBL) CEO Wayne Hooper talks about the company's strong 1H21 results despite the impact of COVID-19, its focus on growth opportunities to expand its national footprint, and business strategy, including potential growth via acquisitions.

31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 327, its expanding portfolio of synthetic anti-infectives targeting viral pathogens and a broad range of bacteria, clinical trial results and priorities for 2021.

29 Mar 2021 - XTEK Limited (ASX:XTE) Managing Director Philippe Odouard talks 1H21 results, discussing the company's expanded operational capacity to meet demand for its high-value proprietary solutions in a favourable market environment for domestic and global defence industries.